Comparative Pharmacology
Head-to-head clinical analysis: MINOXIDIL EXTRA STRENGTH FOR MEN versus PRISCOLINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MINOXIDIL EXTRA STRENGTH FOR MEN versus PRISCOLINE.
MINOXIDIL EXTRA STRENGTH (FOR MEN) vs PRISCOLINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Minoxidil is a potassium channel opener that causes direct vasodilation of peripheral arterioles. It increases blood flow to hair follicles and prolongs the anagen (growth) phase of hair follicles.
Priscoline (tolazoline) is a competitive alpha-adrenergic receptor antagonist; also has direct vasodilatory and histamine-like effects, leading to peripheral vasodilation and decreased peripheral vascular resistance.
Topical: 1 mL of 5% solution (50 mg) applied to the scalp twice daily. Maximum daily dose: 2 mL (100 mg).
10-50 mg subcutaneously or intramuscularly every 4-6 hours; intravenous administration (10 mg slow IV push) reserved for acute vasospastic episodes.
None Documented
None Documented
Terminal elimination half-life is approximately 4.2 hours in patients with normal renal function. However, the pharmacodynamic half-life (duration of antihypertensive effect) is about 24 hours, allowing once-daily dosing.
Terminal elimination half-life is approximately 3-4 hours in adults; prolonged in renal impairment.
Primarily renal (approximately 95% as parent drug and metabolites). Biliary/fecal excretion is minimal (less than 5%).
Primarily renal excretion of unchanged drug (approximately 90%); minor fecal excretion (<10%).
Category A/B
Category C
Vasodilator / Hair Growth Stimulant
Vasodilator